Sunzen Biotech Bhd operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Sunzen Biotech Bhd with three other
miscellaneous service companies in Asia:
Crown Bioscience International
sales of 2.24 billion Taiwanese Dollars [US$74.90 million]
of which 100%
was Preclinical Drug Research),
of South Korea
(101.79 billion Korean Won [US$94.57 million]
of which 60%
was NGS), and
Linical Company Limited
based in Japan
(8.36 billion Japanese Yen [US$75.37 million]
of which 90%
was Cro Business).
Sales increased substantially in 2017:
During the year ended December of 2017, sales at
Sunzen Biotech Bhd were 303.45 million Malaysian Ringgits (US$76.49 million).
increase of 658.4%
versus 2016, when the company's sales were 40.01 million Malaysian Ringgits.